Effect of the LEVAmethod by Bertz et al © in Subjects With Overweight or Obesity in Primary Health Care.

Placebo-Controlled, Randomized Weight Loss InterventionTrial in Subjects With Overweight or Obesity in Primary Health Care

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04184479

Acronym

LEVA-POP

Enrollment

200

Registered

2019-12-03

Start date

2020-12-02

Completion date

2027-08-31

Last updated

2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Keywords

overweight, randomized controlled trial, obesity, weight loss, weight loss maintenance

Brief summary

This study evaluates weight loss effect of the method LEVA by Bertz et al in subjects with overweight or obesity that are remitted to Primärvårdens Dietistenhet.

Detailed description

The method Lifestyle at Effective Weight Loss During Breastfeeding (LEVA method by Bertz et al) has been scientifically studied to provide sustainable weight loss for women with overweight or obesity after childbirth. Primary health care centers in Västra Götalandsregionen treat adult patients with overweight and obesity. If the LEVA method by Bertz et el also produces weight loss to other patient groups than women post partum, the method could be used as a treatment alternative.

Interventions

BEHAVIORALLEVAmethod by Bertz et al

Ordinary treatment

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* BMI 27 ≤ 35 * age 18-75 år

Exclusion criteria

* difficulty understanding Swedish, spoken or read * does not manage/want to handle digital Tools * the remittance was addressed to Primärvårdens Dietistenhet at wrong premises and the patient should be treated elsewhere.

Design outcomes

Primary

Measure	Time frame	Description
Change of weight between intervention group and placebo	From baseline and 12 weeks	Weight in kg measured at visits

Secondary

Measure	Time frame	Description
Gender differences in weight loss results	From baseline to 12 weeks	weight in kg measured at visits in relation to gender
Age differences in weight loss results	From baseline to 12 weeks	Weight in kg measured at visits in relation to age
Weight loss result in relation to pre-treatment BMI	From baseline to 12 weeks	Weight in kg measured at visits in relation to pre-treatment BMI
Cost-effectiveness of LEVA method by Bertz et al	From baseline to 12 weeks	Calculation of cost-effectiveness by the method of monetary net benefit

Countries

Sweden

Contacts

Primary ContactElse Johansson

else.hellebo.johansson@vgregion.se+46768871219

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026